Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 230.95 | N/A |
| PEG Ratio (TTM) | 1.39 | N/A |
| P/S Ratio (TTM) | 7.82 | N/A |
| P/B Ratio (TTM) | 1.35 | N/A |
| P/FCF Ratio (TTM) | 22.81 | N/A |
| Price to 5YR AVG Earnings Ratio | -165.32 | N/A |
| Price to 5YR AVG FCF Ratio | 30.30 | N/A |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.26% | N/A |
| ROE (TTM) | 0.63% | N/A |
| Net Profit Margin (TTM) | 3.07% | N/A |
| ROIC 5YR AVG | 1.01% | N/A |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 219.51% | -101.33% | -108.08% |
| Revenue | 2.61% | 4.54% | 5.80% |
| Net Income | 240.53% | -102.78% | -111.00% |
| Cash Flow | 23.38% | 5.13% | 11.84% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.94 | N/A |
| Quick Ratio (TTM) | 1.94 | N/A |
| D/E Ratio (TTM) | 0.82 | N/A |
| Interest Coverage (TTM) | 0.79 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.01 | N/A |
| LTL to 5YR AVG FCF | 18.17 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.06% | N/A |